As part of the International Conference on One Medicine One Science (iCOMOS) taking place April 24-27, the University of Minnesota will present a session on Canine and Human Epilepsy on April 27.
Presented by the U of M College of Veterinary Medicine, Mayo Clinic, National Institute of Health, National Institute of Neurologic al Disorders and Stroke, and the Epilepsy Foundation of Minnesota, the workshop will feature leading experts in epilepsy and updates on the latest treatments for humans and canines with epilepsy.
Directed to researchers, physicians, epilepsy patients and their families; and dog owners, the workshop will explore epilepsy research and medical treatments including drugs, devices and medical cannabis.
According to Ned Patterson, DVM, Ph.D. at University of Minnesota's College of Veterinary Medicine, the workshop will include presentations on promising treatments that have been tested on canines with epilepsy. "We're hopeful that these therapies can influence future directions of epilepsy research to treat people and dogs alike with epilepsy." At the University of Minnesota, physicians, pharmacists and veterinarians have been collaborating across health disciplines to further research. It is part of the university's commitment to One Health-- an integrated approach to human, animal and environmental health.
Speakers include Mike Rogawski, Ph.D., of University of California-Davis: Gregory Worrell, M.D, Ph.D. Mayo Clinic; Mike Podell, DVM, M.S. MedVet Medical and Cancer Center for Pets; and Ilo Leppik M.D., University of Minnesota College of Pharmacy.
Epilepsy research has made great strides in the past few years," says Vicki Kopplin, Executive Director of the Epilepsy Foundation of MN. "To have these resources and experts convene for this workshop in Minnesota is a tremendous opportunity."
New insights into stiff-person syndrome, advancing diagnosis and treatment